UniProt ID | TNIP2_HUMAN | |
---|---|---|
UniProt AC | Q8NFZ5 | |
Protein Name | TNFAIP3-interacting protein 2 | |
Gene Name | TNIP2 {ECO:0000312|EMBL:EAW82514.1} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 429 | |
Subcellular Localization | Cytoplasm . Nucleus . | |
Protein Description | Inhibits NF-kappa-B activation by blocking the interaction of RIPK1 with its downstream effector NEMO/IKBKG. Forms a ternary complex with NFKB1 and MAP3K8 but appears to function upstream of MAP3K8 in the TLR4 signaling pathway that regulates MAP3K8 activation. Involved in activation of the MEK/ERK signaling pathway during innate immune response; this function seems to be stimulus- and cell type specific. Required for stability of MAP3K8. Involved in regulation of apoptosis in endothelial cells; promotes TEK agonist-stimulated endothelial survival. May act as transcriptional coactivator when translocated to the nucleus. Enhances CHUK-mediated NF-kappa-B activation involving NF-kappa-B p50-p65 and p50-c-Rel complexes.. | |
Protein Sequence | MSRDPGSGGWEEAPRAAAALCTLYHEAGQRLRRLQDQLAARDALIARLRARLAALEGDAAPSLVDALLEQVARFREQLRRQEGGAAEAQMRQEIERLTERLEEKEREMQQLLSQPQHEREKEVVLLRRSMAEGERARAASDVLCRSLANETHQLRRTLTATAHMCQHLAKCLDERQHAQRNVGERSPDQSEHTDGHTSVQSVIEKLQEENRLLKQKVTHVEDLNAKWQRYNASRDEYVRGLHAQLRGLQIPHEPELMRKEISRLNRQLEEKINDCAEVKQELAASRTARDAALERVQMLEQQILAYKDDFMSERADRERAQSRIQELEEKVASLLHQVSWRQDSREPDAGRIHAGSKTAKYLAADALELMVPGGWRPGTGSQQPEPPAEGGHPGAAQRGQGDLQCPHCLQCFSDEQGEELLRHVAECCQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSRDPGSGG ------CCCCCCCCC | 45.45 | - | |
7 | Phosphorylation | -MSRDPGSGGWEEAP -CCCCCCCCCCCHHH | 39.25 | 23401153 | |
22 | Phosphorylation | RAAAALCTLYHEAGQ HHHHHHHHHHHHHHH | 31.07 | 21712546 | |
24 | Phosphorylation | AAALCTLYHEAGQRL HHHHHHHHHHHHHHH | 4.58 | 21712546 | |
62 | Phosphorylation | LEGDAAPSLVDALLE HHCCCCHHHHHHHHH | 35.98 | 30108239 | |
113 | Phosphorylation | REMQQLLSQPQHERE HHHHHHHCCCHHHHH | 48.70 | 24043423 | |
121 | Ubiquitination | QPQHEREKEVVLLRR CCHHHHHHHHHHHHH | 63.13 | - | |
129 | Phosphorylation | EVVLLRRSMAEGERA HHHHHHHHHHHHHHH | 18.86 | - | |
140 | Phosphorylation | GERARAASDVLCRSL HHHHHHHHHHHHHHH | 27.54 | 27251275 | |
146 | Phosphorylation | ASDVLCRSLANETHQ HHHHHHHHHHHHHHH | 30.73 | 30108239 | |
170 | Ubiquitination | HMCQHLAKCLDERQH HHHHHHHHHHHHHHH | 41.51 | - | |
186 | Phosphorylation | QRNVGERSPDQSEHT HHCCCCCCCCCCCCC | 28.64 | 23401153 | |
190 | Phosphorylation | GERSPDQSEHTDGHT CCCCCCCCCCCCCCC | 38.43 | 23663014 | |
193 | Phosphorylation | SPDQSEHTDGHTSVQ CCCCCCCCCCCCHHH | 39.36 | 23663014 | |
197 | Phosphorylation | SEHTDGHTSVQSVIE CCCCCCCCHHHHHHH | 35.80 | 29255136 | |
198 | Phosphorylation | EHTDGHTSVQSVIEK CCCCCCCHHHHHHHH | 16.69 | 29255136 | |
201 | Phosphorylation | DGHTSVQSVIEKLQE CCCCHHHHHHHHHHH | 23.94 | 29255136 | |
205 | Ubiquitination | SVQSVIEKLQEENRL HHHHHHHHHHHHCHH | 44.33 | - | |
279 | Ubiquitination | INDCAEVKQELAASR HHHHHHHHHHHHHHH | 29.56 | - | |
330 | Ubiquitination | RIQELEEKVASLLHQ HHHHHHHHHHHHHHH | 33.45 | - | |
333 | Phosphorylation | ELEEKVASLLHQVSW HHHHHHHHHHHHHHC | 34.16 | 30108239 | |
339 | Phosphorylation | ASLLHQVSWRQDSRE HHHHHHHHCCCCCCC | 15.24 | 27273156 | |
344 | Phosphorylation | QVSWRQDSREPDAGR HHHCCCCCCCCCCCC | 30.15 | 26699800 | |
356 | Phosphorylation | AGRIHAGSKTAKYLA CCCCCCCHHHHHHHH | 27.84 | 27273156 | |
357 | Ubiquitination | GRIHAGSKTAKYLAA CCCCCCHHHHHHHHH | 52.14 | - | |
361 | Phosphorylation | AGSKTAKYLAADALE CCHHHHHHHHHHHHH | 10.10 | 27642862 | |
413 | Phosphorylation | PHCLQCFSDEQGEEL CCHHHHCCHHHHHHH | 48.11 | 30108239 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TNIP2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TNIP2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TNAP3_HUMAN | TNFAIP3 | physical | 21266526 | |
M3K8_HUMAN | MAP3K8 | physical | 15169888 | |
NFKB1_HUMAN | NFKB1 | physical | 15169888 | |
NEMO_HUMAN | IKBKG | physical | 14653779 | |
IKKA_HUMAN | CHUK | physical | 21784860 | |
IKKB_HUMAN | IKBKB | physical | 21784860 | |
SMRD1_HUMAN | SMARCD1 | physical | 12753905 | |
TIE2_HUMAN | TEK | physical | 12609966 | |
STK11_HUMAN | STK11 | physical | 12595760 | |
A4_HUMAN | APP | physical | 21832049 | |
UBC_HUMAN | UBC | physical | 19373254 | |
UBC_HUMAN | UBC | physical | 27916521 | |
UBP35_HUMAN | USP35 | physical | 26348204 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186, AND MASSSPECTROMETRY. |